Oxidative stress status during the acute phase of haemolytic uraemic syndrome

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 858-864

  Ferraris, Veronica ^a   Acquier, Andrea ^c   Ferraris, Jorge R ^a   Vallejo, Graciela ^b   Paz, Cristina ^c   Mendez, Carlos F ^c  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

acute renal failure; haemolytic uraemic syndrome; oxidative stress

Indexed keywords

THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 79952170338     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq511     Document Type: Article

References (34)

1. Gasser C, Gautier E, Steck A et al. Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 1955;85:905-909
2. Gianantonio CA, Vitacco M, Mendilaharzu J et al. Acute renal failure in infancy and childhood. Clinical course and treatment of 41 patients. J Pediatr 1962;61:660-678
3. Spizzirri F, Rahman R, Bibiloni N et al. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 1997;11:156-160 (Pubitemid 27122682)
4. Caprioli J, Peng L, Remuzzi G. The hemolytic uremic syndromes. Curr Opin Crit Care 2005;11:487-492 (Pubitemid 41482706)
5. Taylor CM. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol 2008;23:1425-1431
6. Ruggenenti P, Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 1990;4:219-241 (Pubitemid 20095147)
7. Kaplan B, Cleary T, Obrig T. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 1990;4:276-283 (Pubitemid 20187011)
8. Johnson S, Taylor CM. What's new in haemolytic uraemic syndrome? Eur J Pediatr 2008;167:965-971
9. Powell HR, McCredie DA, Taylor CM et al. Vitamin e treatment of haemolytic uraemic syndrome. Arch Dis Child 1984;59:401-404 (Pubitemid 14105897)
10. Brown RE, Alade S, Knight J et al. Serum lipoperoxidation products in an infant with hemolytic-uremic syndrome. Clin Chem 1988;34:2382-2384 (Pubitemid 19001297)
11. Levin M, Elkon KB, Nokes TJ et al. Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. Arch Dis Child 1983;58:703-708 (Pubitemid 13007594)
12. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-295 (Pubitemid 27182306)
13. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S-38S
14. Erdogan H, Fadillioglu E, Yagmurca M et al. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 2006;34:41-46 (Pubitemid 43234713)
15. Bonventre J, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003;14:2199-2210 (Pubitemid 36909930)
16. Morena M, Delbosc S, Dupuy AM et al. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005;9:37-46 (Pubitemid 40932774)
17. Zwolinska D, Grzeszczak W, Szczepanska M et al. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis. Pediatr Nephrol 2006;21:705-710
18. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;39:2522-2526 (Pubitemid 24008241)
19. Lissi E, Salim-Hanna M, Pascual C et al. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminolenhanced chemiluminescence measurements. Free Radic Biol Med 1995;18:153-158
20. Vargas C, Wajner M, Sirtori L et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 2004;1688:26-32 (Pubitemid 38366303)
21. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Ann Rev Nutr 1985;5:365-390
22. Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci 1991;48:301-309
23. Scandalios J. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 2005;38:995-1014 (Pubitemid 41078961)
24. Knight J, Smith S, Kinder V et al. Reference intervals for plasma lipoperoxides: age-, sex-, and specimen-related variations. Clin Chem 1987;33:2289-2291
25. Nielsen F, Mikkelsen B, Nielsen J et al. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of lifestyle factors. Clin Chem 1997;43:1209-1214 (Pubitemid 27297265)
26. Andreazza A, Bordin D, Salvador M. Thiobarbituric acid-reactive substances, seric superoxide dismutase and catalase activities in healthy subjects. Clin Chim Acta 2005;362:192-194 (Pubitemid 41597106)
27. O'Regan S, Chesney RW, Kaplan BS et al. Red cell membrane phospholipid abnormalities in the hemolytic uremic syndrome. Clin Nephrol 1981;15:14-17 (Pubitemid 11184529)
28. Facorro G, Aguirre F, Florentin L et al. Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome. Acta Physiol Pharmacol Ther Latinoam 1997;47:137-146
29. Túri S, Németh I, Vargha I et al. Oxidative damage of red blood cells in haemolytic uraemic syndrome. Pediatr Nephrol 1994;8:26-29 (Pubitemid 24042361)
30. Jones D. Redefining oxidative stress. Antioxid Redox Signal 2006;8:1865-1879 (Pubitemid 44726359)
31. Yousefipour Z, Oyekan A, Newaz M. Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor γ in acute renal failure. Pharmacol Ther 2010;125:436-445
32. Himmelfarb J, Mcmonagle E, Freedman S et al. Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 2004;15:2449-2456 (Pubitemid 39159345)
33. Mishra OP, Pooniya V, Ali Z et al. Antioxidant status of children with acute renal failure. Pediatr Nephrol 2008;23:2047-2051
34. Balakrishnan V, Blumberg J, Pereira B et al. Antioxidant and oxidative stress indices in dialysis-dependent acute renal failure. Blood Purif 2003;21:213-219 (Pubitemid 36649369)